Summary
- Main use
- Protects liver cells and provides adjunctive treatment for liver diseases (e.g., chronic hepatitis and cirrhosis)
- Who takes it
- Adults
- Adult dose
- (Tablets)(Oral solution)(Suspension) Adults: Take 35-140mg of silymarin (or 15-60 mg of silibinin) per dose, 3 times daily. (Capsules) Adults: Initial dose: 140mg of silymarin (or 60mg of silibinin) per dose, 3 times daily; maintenance dose: 70mg of silymarin (or 30mg of silibinin) per dose, 3 times daily [or 140mg of silymarin (or 60mg of silibinin) per dose, 2 times daily].
Ingredients
- Manufacturer
- Youngil Pharmaceutical Co., Ltd.
Efficacy & effects
Protects liver cells and provides adjunctive treatment for liver diseases (e.g., chronic hepatitis and cirrhosis)
- Toxic liver disease
- chronic hepatitis
- cirrhosis
View approved original textHide original text
This medication is used as an adjunct therapy for liver diseases such as toxic liver disease, chronic hepatitis, and cirrhosis. It also helps to protect liver cells and improve liver function. The tablet, liquid, and suspension forms are also applicable in treatments related to liver cell protection. Capsules are primarily used as adjunct therapy for toxic liver disease, chronic hepatitis, and cirrhosis. These various formulations contribute to alleviating patients' symptoms.
How to take
Adult dose
(Tablets)(Oral solution)(Suspension) Adults: Take 35-140mg of silymarin (or 15-60 mg of silibinin) per dose, 3 times daily. (Capsules) Adults: Initial dose: 140mg of silymarin (or 60mg of silibinin) per dose, 3 times daily; maintenance dose: 70mg of silymarin (or 30mg of silibinin) per dose, 3 times daily [or 140mg of silymarin (or 60mg of silibinin) per dose, 2 times daily].
Precautions
This medication should not be taken by patients with severe biliary obstruction. Additionally, individuals who have allergic reactions to this medication should avoid use. It is not safe for children under 12 years of age to use this medication. This medication contains lactose; therefore, individuals with lactose intolerance, genetic lactose deficiency, or glucose-galactose malabsorption should refrain from taking it. Pregnant or breastfeeding women must consult a doctor or pharmacist before taking this medication. If symptoms such as stomach pain or diarrhea occur while taking this medication, consumption should be immediately stopped and a healthcare professional consulted. In case of an allergic reaction, consumption should also be stopped immediately and a healthcare provider should be notified. Dosage and administration should strictly follow the prescribed guidelines, and consultation with a healthcare professional is essential if jaundice symptoms present. If symptoms do not improve after one month or if used for a prolonged period, consultation with a doctor or pharmacist is important. This medication should be kept out of reach of children and stored in a cool, dry place away from direct sunlight. Medicines should be kept in their original container and should not be transferred to another container to maintain quality. Finally, this medication contains the dye Tartrazine (Yellow No. 4), and those allergic or sensitive to this ingredient should take care when using it.
Side effects
- Stomach pain
- diarrhea
- allergic reactions
Not everyone experiences these, and they can vary from person to person.
Storage
This medication should be stored in a sealed container to prevent contact with air or moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. Proper storage will help ensure the medication's effectiveness.
Appearance and packaging
Appearance
Red-brown round coated tablets.
Package unit
Self-packaging unit
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.